These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Recommendations on the practice of intracavitary diagnostic methods and treatment of cardiac arrhythmias. Diagnostic electrophysiology; interventional electrophysiology; permanent cardiac stimulation; automatic implantable defibrillators]. Daubert JC; Lévy S; Medvedowsky JL Arch Mal Coeur Vaiss; 1998 Jan; (1 Suppl):15-26. PubMed ID: 9749288 [No Abstract] [Full Text] [Related]
8. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI). Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683 [TBL] [Abstract][Full Text] [Related]
9. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices. Samii SM Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883 [TBL] [Abstract][Full Text] [Related]
10. Initial experience of subcutaneous implantable cardioverter defibrillators in Singapore: a case series and review of the literature. Lim TS; Tan BY; Ho KL; Lim CY; Teo WS; Ching CK Singapore Med J; 2015 Oct; 56(10):580-5. PubMed ID: 26512151 [TBL] [Abstract][Full Text] [Related]
12. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. Credner SC; Klingenheben T; Mauss O; Sticherling C; Hohnloser SH J Am Coll Cardiol; 1998 Dec; 32(7):1909-15. PubMed ID: 9857871 [TBL] [Abstract][Full Text] [Related]
13. Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators. Van Herendael H; Pinter A; Ahmad K; Korley V; Mangat I; Dorian P Europace; 2010 May; 12(5):618-25. PubMed ID: 20304841 [TBL] [Abstract][Full Text] [Related]
14. [The treatment of malignant ventricular arrhythmias with implantable cardioverter-defibrillators: a reality but still with numerous questions]. Arenal A; Almendral J; Albertos J Rev Esp Cardiol; 1992 Jan; 45(1):1-4. PubMed ID: 1549756 [No Abstract] [Full Text] [Related]
15. The year in review of clinical cardiac electrophysiology. Marcus GM; Keung E; Scheinman MM J Am Coll Cardiol; 2009 Aug; 54(9):777-87. PubMed ID: 19695454 [No Abstract] [Full Text] [Related]
16. Spanish Implantable Cardioverter-Defibrillator Registry. Sixth official report of the Spanish Society Of Cardiology Working Group on Implantable Cardioverter-defibrillators (2009). Alzueta J; Linde A; Barrera A; Peña J; Peinado R Rev Esp Cardiol; 2010 Dec; 63(12):1468-81. PubMed ID: 21144407 [TBL] [Abstract][Full Text] [Related]
17. The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions. Verma N; Rhyner J; Knight BP Expert Rev Cardiovasc Ther; 2015; 13(9):989-99. PubMed ID: 26308601 [TBL] [Abstract][Full Text] [Related]
18. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies. Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327 [TBL] [Abstract][Full Text] [Related]
19. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators. Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354 [TBL] [Abstract][Full Text] [Related]
20. ED evaluation and management of implantable cardiac defibrillator electrical shocks. Iftikhar S; Mattu A; Brady W Am J Emerg Med; 2016 Jun; 34(6):1140-7. PubMed ID: 26993075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]